Back to search

West Virginia University

Nuclear factor-κB signal transduction: Development of a novel regulatory strategy.

Abstract

dc:description.abstract

The overall goal of this project was to investigate the feasibility of a new strategy to inhibit the NF-κB signal transduction pathway. Peptide P1 that resembled IκBα , the intracellular inhibitor’s kinase binding domain was designed to competitively inhibit IκBα’s degradation. Preliminary results in stably transfected cells indicated that P1 produced a two-fold inhibition in NF-κB dependent luciferase activity in Lipopolysaccharide (LPS) stimulated RAW cell line, but not in BEAS-2B cell line. A transient transfection protocol was optimized in the BEAS-2B cell line and the effect of P1 was compared to SN50 a known inhibitor of NF-κB pathway. Our results showed that P1 produced a more potent inhibition in these studies. TNF-α ELISA results also indicated that P1 inhibited NF-κB dependent TNF-α production. Western Blot results indicated that LPS stimulated degradation of IκBα was also inhibited by P1 but not by P2, a control peptide indicating that our peptide was both potent and specific.

Degree

thesis:*
Name thesis:degree_name
MS
Level thesis:degree_level
Thesis

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Swaroop, Navin V.
Contributors dc:contributor
  • Yon Rojanasakul

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
West Virginia University
Base URL
researchrepository.wvu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Swaroop, Navin V.. Nuclear factor-κB signal transduction: Development of a novel regulatory strategy.. Thesis thesis, https://doi.org/10.33915/etd.10532